Friday, September 18, 2020
Home > AZN

AstraZeneca Resumes Trials for COVID-19 Vaccine, AZN Stock Slightly Up

In partnership with U.K.’s Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK’s Medicines Health Regulatory Authority. After pausing its work on the coronavirus vaccine citing safety concerns last week, pharmaceutical giant AstraZeneca plc

Read More

AZN Strong H1 Performance, AstraZeneca Advances Vaccine Trials

With the company’s ongoing late-stage clinical trials and its impressive H1 performance results, AstraZeneca (AZN) stock jumped in the pre-market.Foremost leader in the search for COVID-19 vaccine AstraZeneca Plc (NYSE: AZN) has posted its H1 performance report. The company’s released result shows an impressive earning spiked by increasing demand for

Read More